46 results
Page 2 of 3
8-K
EX-99.1
uef0 qm65io
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
424B3
nwwg39nvdc2i7c xnk
14 Jan 22
Prospectus supplement
5:18pm
424B5
o3n74 cgzpxshy1
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
qa7pds9
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
spmp3rc74bnx2jx
22 Nov 21
Definitive proxy
4:37pm
424B5
khc9b58lz 32m
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
dnf0yj5inh6f
14 May 21
Quarterly report
4:31pm
10-K
umxikls
31 Mar 21
Annual report
4:30pm
10-K
EX-10.2
dkzf3ap zyq
31 Mar 21
Annual report
4:30pm
S-3
1cndl
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.2
oeitvc1z0fiwyoqib
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-99.1
vqxd6mv4i
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-99.1
buenjdfihek
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
q5d7lb7x
2 Nov 20
Prospectus supplement
12:00am